The asthma It is one of the most common chronic respiratory diseases, with estimates reporting that about 300 million people worldwide have it.
Although asthma has been known for centuries, its detailed firing mechanisms, the importance of biological factors and new treatment methods are constantly at the heart of scientific research.
Asthma is a complex chronic condition with complex pathophysiology.
The biological factors and innovative rely on them have provided new opportunities for its more effective and more targeted treatment.
Informing patients, working with a specialist pulmonologist and personalized therapeutic approach are keys to controlling symptoms and improving the quality of life of people living with asthma.
What does asthma trigger
Asthma is an inflammatory airway condition characterized by periodic stenosis of the bronchi. This stenosis manifests itself as shortness of breath, wheezing, coughing and tightening in the chest. Cleansing factors are significantly different from person to person, but there are some common triggering factors:
- Allergen: Dust, plant pollen, mold, pet hair.
- Air pollution: Especially in urban areas, pollution can trigger symptoms.
- Respiratory infections: Viral infections such as the common cold and influenza are frequent releasing factors.
- Intense physical activity: Although physical activity generally promotes health, some patients experience so -called asthma from fatigue.
- Emotional stress: Intense emotional states can affect the operation of the airways.
- Climatic agents: Abrupt temperature changes or high humidity can aggravate asthma symptoms.
The importance of biological factor
In recent years, research on asthma biology has evolved rapidly, recognizing that asthma is not a single disease, but has many different phenotypes and biological mechanisms. The biological agent in asthma It refers to the specific molecular and cellular mechanisms that determine the appearance and evolution of the condition.
Particularly important are the so -called biomarkers (biomarkers). These are specific biological substances, such as immunoglobulins, cells or cytokines, which are found in the body and allow specialists to identify the particular form of asthma of each patient.
Biological agents are often associated with allergic forms of asthma, with a more characteristic example being increased production of immunoglobulin E (IgE), a protein involved in the immune response to allergens.
Treatment with biological agents
Modern therapeutic options are now aimed at just pathophysiology and the biological mechanisms that lead to asthma. Thus, the so -called “biological agents” have been developed, which are specialized in specific mechanisms.
These treatments are administered with subcutaneous or intravenous injections and are particularly effective, especially for patients with severe asthma and do not sufficiently respond to conventional treatments (inhaled steroids and bronchodilators).
The importance of personalized approach
The modern perception of asthma is focused on personalization. The treatments are adapted to each patient, depending on their personal profile, their particular needs and the response to previous treatments.
Regular medical monitoring, history taking, diagnostic tests and biomarkers’ testing contribute to the engraving of a strategy that is perfectly adapted to each patient individually.